Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller Farhat Nasim29 Jan 2025 8:04 PM ISTMumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....
Novartis Entresto US patent upheld by US Court of Appeals Ruchika Sharma15 Jan 2025 3:30 PM ISTBasel: Novartis has announced that the Company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the...
US Appeals Court decision favors MSN Pharma in Novartis heart drug Entresto generic dispute Ruchika Sharma9 Dec 2024 10:00 AM ISTNovartis suffered a legal setback on Wednesday as the company failed to persuade a U.S. appeals court to halt MSN Pharmaceuticals' proposed generic of...
Entresto: Novartis loses initial bid to block generic of blockbuster heart drug Ruchika Sharma14 Aug 2024 11:30 AM ISTLondon: Novartis, a leading pharmaceutical company, has failed in its attempt to convince a federal court to block MSN Pharmaceuticals, a generic...
USFDA nod to Zydus Lifesciences chronic heart failure drug Ruchika Sharma10 July 2024 5:20 PM ISTSacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalization.
Novartis in advanced talks to buy Cytokinetics: Source Ruchika Sharma10 Jan 2024 3:30 PM ISTAccess to Cytokinetics products would help Novartis offset the expected loss of U.S. exclusivity of Entresto, its key drug in this field, said...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Novartis to appeal to US Court of Appeals to uphold validity of Entresto combination patent Ruchika Sharma8 July 2023 3:00 PM ISTBasel: Novartis has announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent...
Novartis Entresto receives positive CHMP opinion for pediatric heart failure Ruchika Sharma2 April 2023 2:00 PM ISTPediatric heart failure represents an important cause of morbidity and mortality in childhood.
Operating profit to grow again ahead of Sandoz spin off: Novartis Ruchika Sharma1 Feb 2023 10:00 AM ISTNovartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its...
Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 6:26 PM ISTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Novartis in tight spot as HC stays grant of patent for Entresto amid generics fight Farhat Nasim13 Jan 2023 11:59 AM ISTNew Delhi: Amid the earlier patent of blockbuster heart failure drug Entresto expiring on January 16, 2023 concerns rise for the Swiss multinational...
